SEC Form 4 · accession 0001209191-17-042554
Xylem Inc. · XYL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven R Loranger
Director
Period of report
Jun 28, 2017
Accepted (ET)
Jun 30, 2017 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001524472
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 28, 2017 | M | 56,199 | $30.0295 | A | 65,030 | D | |
| Common StockF1,F2 | Jun 28, 2017 | S | 56,199 | $55.002 | D | 8,831 | D | |
| Common StockF1 | Jun 29, 2017 | M | 9,933 | $30.0295 | A | 18,764 | D | |
| Common StockF1,F3 | Jun 29, 2017 | S | 9,933 | $55.049 | D | 8,831 | D | |
| Common Stock | holding | — | — | — | 130,918 | I | By Steven R. Loranger Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $30.03 | Jun 28, 2017 | M | 56,199 | D | — | Oct 31, 2018 | Common Stock | 56,199 | 9,933 | D |
| Stock option (right to buy)F4 | $30.03 | Jun 29, 2017 | M | 9,933 | D | — | Oct 31, 2018 | Common Stock | 9,933 | 0 | D |
Explanation of responses
- F1The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on June 1, 2016.
- F2This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $55.00 to $55.02 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
- F3This price represents the approximate weighted average price per Share of the Issuer that were executed at prices ranging from $55.00 to $55.30 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
- F4These options are fully vested and exercisable.